Kohlberg Kravis Roberts & Co’s Calidi Biotherapeutics CLDI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-294	Closed	-$351K	–	216
2022 Q2	$351K	Hold	294	–	–	﹤0.01%	179
2022 Q1	$349K	Buy	294 +73	+33%	+$86.7K	﹤0.01%	191
2021 Q4	$260K	Buy	+221	New	+$260K	﹤0.01%	158